Cargando…

Impact of COVID-19 Disruptions on Global BCG Coverage and Paediatric TB Mortality: A Modelling Study

The impact of COVID-19 disruptions on global Bacillus Calmette-Guérin (BCG) coverage and paediatric tuberculosis (TB) mortality is still unknown. To fill this evidence-gap and guide mitigation measures, we estimated the impact of COVID-19 disruptions on global BCG coverage and paediatric TB mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaikh, Nabila, Pelzer, Puck T., Thysen, Sanne M., Roy, Partho, Harris, Rebecca C., White, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624525/ https://www.ncbi.nlm.nih.gov/pubmed/34835161 http://dx.doi.org/10.3390/vaccines9111228

Ejemplares similares

Potential effect of age of BCG vaccination on global paediatric tuberculosis mortality: a modelling study
por: Roy, Partho, et al.
Publicado: (2019)

Disregarding the restrictive vial-opening policy for BCG vaccine in Guinea-Bissau: impact and cost-effectiveness for tuberculosis mortality and all-cause mortality in children aged 0–4 years
por: Thysen, Sanne M, et al.
Publicado: (2021)

The potential impact of BCG vaccine supply shortages on global paediatric tuberculosis mortality
por: Harris, Rebecca C., et al.
Publicado: (2016)

BCG coverage and barriers to BCG vaccination in Guinea-Bissau: an observational study
por: Thysen, Sanne Marie, et al.
Publicado: (2014)

Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
por: Thysen, Sanne M, et al.
Publicado: (2020)

Can BCG vaccination at first health-facility contact reduce early infant mortality? Study protocol for a cluster-randomised trial (CS-BCG)
por: Thysen, Sanne Marie, et al.
Publicado: (2022)

Comment on the trial protocol “Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial”
por: Thysen, Sanne Marie, et al.
Publicado: (2019)

Can earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-Bissau
por: Thysen, Sanne M, et al.
Publicado: (2019)

Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines
por: Pelzer, Puck T., et al.
Publicado: (2022)

Vaccination with BCGΔBCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG
por: Aceves-Sánchez, Michel de Jesús, et al.
Publicado: (2021)

Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study
por: Funch, Katarina M., et al.
Publicado: (2018)

Is Global BCG Vaccination Coverage Relevant To The Progression Of SARS-CoV-2 Pandemic?
por: Gursel, Mayda, et al.
Publicado: (2020)

Assessment of training and mentoring for DR-TB care decentralization in Tanzania
por: Lyakurwa, Dennis, et al.
Publicado: (2021)

Global impact of environmental temperature and BCG vaccination coverage on the transmissibility and fatality rate of COVID-19
por: Kumar, Amit, et al.
Publicado: (2020)

Evaluation of early innate and adaptive immune responses to the TB vaccine Mycobacterium bovis BCG and vaccine candidate BCGΔBCG1419c
por: Gunasena, Manuja, et al.
Publicado: (2022)

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
por: Pooransingh, Shalini, et al.
Publicado: (2020)

TB infection and BCG vaccination: are we protected from COVID-19?
por: Madan, M., et al.
Publicado: (2020)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019
por: Atalell, Kendalem Asmare, et al.
Publicado: (2022)

‘Fight TB with BCG’: Mass Vaccination Campaigns in the British Caribbean, 1951–6
por: Altink, Henrice
Publicado: (2014)

761. Age-Related Incidence of TB Infection Supporting Efficacy of BCG Vaccination
por: Sweeney, Eileen, et al.
Publicado: (2018)

Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease
por: Yao, Qiong, et al.
Publicado: (2022)

Variances in BCG protection against COVID-19 mortality: A global assessment
por: Sarfraz, Zouina, et al.
Publicado: (2021)

An Update on Global Tuberculosis (TB)
por: Talip, Balkis A., et al.
Publicado: (2013)

Out-of-sequence DTP and measles vaccinations and child mortality in Guinea-Bissau: a reanalysis
por: Thysen, Sanne M, et al.
Publicado: (2019)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countries
por: Whittaker, Elizabeth, et al.
Publicado: (2018)

The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
por: Zwerling, Alice, et al.
Publicado: (2011)

An Overview of Coverage of BCG Vaccination and Its Determinants Based on Data from the Coverage Survey in Zhejiang Province
por: Hu, Yu, et al.
Publicado: (2018)

Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021)

Determinants of BCG vaccination coverage in Ethiopia: a cross-sectional survey
por: Tsehay, Asmamaw Ketemaw, et al.
Publicado: (2019)

Relation between BCG coverage rate and COVID-19 infection worldwide
por: Macedo, A., et al.
Publicado: (2020)

COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
por: Garzon-Chavez, Daniel, et al.
Publicado: (2021)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
por: White, Andrew D., et al.
Publicado: (2021)

Pre-Clinical Development of BCG.HIVA(CAT), an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG
por: Saubi, Narcís, et al.
Publicado: (2012)

Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming
por: Gonçalves, Eduardo DC, et al.
Publicado: (2007)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Strategy to Better Select HIV-Infected Individuals for Latent TB Treatment in BCG-Vaccinated Population
por: Yang, Chin-Hui, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hdd7ju9d0u3qa44vrdbaks6kdd